Influenza targets

Details for Australian Patent Application No. 2010334799 (hide)

Owner Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.V.

Inventors Machuy, Nikolaus; Karlas, Alexander; Meyer, Thomas F.

Agent Davies Collison Cave

Pub. Number AU-A-2010334799

PCT Pub. Number WO2011/076873

Priority 09015997.1 23.12.09 EP

Filing date 22 December 2010

Wipo publication date 30 June 2011

International Classifications

A61K 31/713 - Double-stranded nucleic acids or oligonucleotides

A61P 31/16 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C12N 15/113 Mutation or genetic engineering - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

Event Publications

12 July 2012 PCT application entered the National Phase

  PCT publication WO2011/076873 Priority application(s): WO2011/076873

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010334804-Aminoalkylpyrimidine derivatives as histamine H4 receptor antagonists

2010334792-Liquid fuel compositions